PSA velocity does not aid long-term prediction of prostate cancer incidence
This article has no abstract so we have provided the first paragraph of the full text.
Elevated serum prostate-specific antigen (PSA) levels can indicate the presence of prostate cancer, although PSA levels are also elevated in some non-malignant conditions, which affects the reliability of prostate cancer prediction. PSA levels rise sharply in patients with aggressive prostate cancer, and a recent study suggested that the rate of increase (PSA velocity) could predict life-threatening prostate cancer 10–15 years before diagnosis. Ulmert and colleagues evaluated data from the Malmö Preventative Medicine population-based study to compare the accuracy of a single PSA measurement versus PSA velocity in the long-term prediction of prostate cancer diagnosis.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.